Real-world evaluation of compliance and preference in Alzheimer’s disease treatment

Real-world evaluation of compliance and preference in Alzheimer’s disease treatment

Ming-Chyi Pai,1,2 Hany Aref,3 Nazem Bassil,4 Nagaendran Kandiah,5 Jae-Hong Lee,6 AV Srinivasan,7 Shelley diTommaso,8 Ozgur Yuksel81Division of Behavioral Neurology, Department of Neurology, 2Alzheimer’s Disease Research Center, National Cheng Kung University Hospital, College of Medicine,...

Full description

Bibliographic Details
Main Authors: Pai MC, Aref H, Bassil N, Kandiah N, Lee JH, Srinivasan AV, diTommaso S, Yuksel O
Format: Article
Language:English
Published: Dove Medical Press 2015-11-01
Series:Clinical Interventions in Aging
Subjects:
Rivastigmine
Alzheimer's disease
cholinesterase inhibitors
patient compliance
observational study
clinical trials
Online Access:https://www.dovepress.com/real-world-evaluation-of-compliance-and-preference-in-alzheimerrsquos--peer-reviewed-article-CIA

Internet

https://www.dovepress.com/real-world-evaluation-of-compliance-and-preference-in-alzheimerrsquos--peer-reviewed-article-CIA

Similar Items